伊貝沙坦心臟保護(hù)作用--預(yù)防心律失常研究進(jìn)展ppt25-經(jīng)營管理(編輯修改稿)
2024-09-20 17:38 本頁面
【文章內(nèi)容簡介】 Irbesartan and atenolol in hypertension and LVH: SILVHIA study design 4 0 12 24 48 Week * * * * Malmqvist K, Kahan T et al. Am J Cardiol 2020:90。110712. 來自 下載 Irb vs. Ate p = Irbesartan p Atenolol p 20 15 10 5 0 12 Week 24 48 12 Week 24 48 DBP % reduction Irbesartan vs. atenolol in hypertension and LVH: DBP reduction 9% 12% 18% 11% 13% 16% Irbesartan Atenolol Malmqvist K, Kahan T et al. J Hypertens 2020:19(6)。116776. 來自 下載 Irbesartan vs. atenolol in hypertension and LVH: LVMI reduction Irb vs. Ate p = Irbesartan p Atenolol p 20 15 10 5 0 12 Week 24 48 Irbesartan Atenolol 12 Week 24 48 LVMI (%) 9% 1% 4% 5% 8% 16% Malmqvist K, Kahan T et al. J Hypertens 2020:19(6)。116776. Irbesartan Reduces QT Dispersion in Hypertensive Individuals Lim PO, et al. Hypertension 1999。33:713 來自 下載 伊貝沙坦與氨氯地平改善 QT離散 QT 離散 (ms) QTc 離散 (ms) QTc max(ms) ? P= ? P= ? P= ? P= ? P= ? P= Irbesartan Amlodipine (n=53) (n=51) 來自 下載 Irbesartan and atenolol in hypertension and LVH: Effects on QT dispersion Irb: p Ate: p = Irb vs Ate: p =
試題試卷相關(guān)推薦
鄂ICP備17016276號(hào)-1